• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化相关性腹水症状量表的制定和预测效度:103 例患者的队列研究。

Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients.

机构信息

Gastro Unit, Medical Davison, Copenhagen University Hospital Hvidovre, Hvidovre 2650, Denmark.

Department of Gastroenterology and Hepatology, Odense University Hospital, Odense C 5000, Denmark.

出版信息

World J Gastroenterol. 2018 Apr 21;24(15):1650-1657. doi: 10.3748/wjg.v24.i15.1650.

DOI:10.3748/wjg.v24.i15.1650
PMID:29686472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5910548/
Abstract

AIM

To develop a scale of domains associated with the health-related quality-of-life (HRQOL) in patients with cirrhosis-related ascites.

METHODS

We initially undertook literature searches and a qualitative study in order to design a cirrhosis-associated ascites symptom (CAS) scale describing symptoms with a potential detrimental impact on health related quality of life (HRQL) (the higher the score, the worse the symptoms). Discriminatory validity was assessed in a validation cohort including cirrhotic patients with (1) tense/severe; (2) moderate/mild; or (3) no ascites (controls). Patients also completed chronic liver disease questionnaire (CLDQ) and the EuroQoL 5-Dimensions 5-Level (EQ-5D-5L) questionnaire evaluating HRQL. The relation between scale scores was analysed using Spearman correlations.

RESULTS

The final CAS scale included 14 items. The equivalent reliability was high (Chronbach's alpha 0.88). The validation cohort included 103 patients (72% men, mean age 62.4 years). The mean scores for each question in the CAS scale were higher for patients with severe/tense ascites than for mild/moderate ascites and controls. Compared with controls (mean = 9.9 points), the total CAS scale score was higher for severe/tense ascites (mean = 23.8 points) as well as moderate/mild ascites (mean = 18.6 points) ( < 0.001 both groups). We found a strong correlation between the total CAS and CLDQ score (rho = 0.82, < 0.001) and a moderate correlation between the CAS and the EQ-5D-5L score (0.67, < 0.001).

CONCLUSION

The CAS is a valid tool, which reflects HRQOL in patients with ascites.

摘要

目的

开发与肝硬化相关腹水患者健康相关生活质量(HRQOL)相关的领域量表。

方法

我们最初进行了文献检索和定性研究,以设计一种描述可能对健康相关生活质量(HRQL)产生不利影响的症状的肝硬化相关腹水症状(CAS)量表(得分越高,症状越严重)。在一个包括肝硬化患者的验证队列中评估了判别效度,这些患者(1)紧张/严重;(2)中度/轻度;或(3)无腹水(对照组)。患者还完成了慢性肝病问卷(CLDQ)和 EuroQoL 5 维度 5 级(EQ-5D-5L)问卷,评估 HRQL。使用 Spearman 相关分析量表评分之间的关系。

结果

最终的 CAS 量表包括 14 个项目。等效可靠性高(Chronbach's alpha 0.88)。验证队列包括 103 名患者(72%为男性,平均年龄 62.4 岁)。CAS 量表中每个问题的平均得分在严重/紧张性腹水患者中高于轻度/中度腹水患者和对照组。与对照组(平均 9.9 分)相比,严重/紧张性腹水患者的总 CAS 量表评分更高(平均 23.8 分),中度/轻度腹水患者的总 CAS 量表评分也更高(平均 18.6 分)(两组均 <0.001)。我们发现总 CAS 与 CLDQ 评分之间存在很强的相关性(rho = 0.82,<0.001),而 CAS 与 EQ-5D-5L 评分之间存在中度相关性(0.67,<0.001)。

结论

CAS 是一种有效的工具,可反映腹水患者的 HRQOL。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c576/5910548/13ef035e2ab7/WJG-24-1650-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c576/5910548/cd0909ee6286/WJG-24-1650-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c576/5910548/13ef035e2ab7/WJG-24-1650-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c576/5910548/cd0909ee6286/WJG-24-1650-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c576/5910548/13ef035e2ab7/WJG-24-1650-g002.jpg

相似文献

1
Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients.肝硬化相关性腹水症状量表的制定和预测效度:103 例患者的队列研究。
World J Gastroenterol. 2018 Apr 21;24(15):1650-1657. doi: 10.3748/wjg.v24.i15.1650.
2
Validation of the chronic liver disease questionnaire in Serbian patients.慢性肝病问卷在塞尔维亚患者中的验证。
World J Gastroenterol. 2013 Aug 14;19(30):4950-7. doi: 10.3748/wjg.v19.i30.4950.
3
Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites.肝硬化腹水症状评估患者报告结局测量工具的开发与验证。
Am J Gastroenterol. 2018 Apr;113(4):567-575. doi: 10.1038/ajg.2018.18. Epub 2018 Mar 20.
4
Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.ECOS-16问卷意大利语版本在患有骨质疏松症所致椎体骨折的绝经后女性中的效度和信度
Clin Exp Rheumatol. 2007 May-Jun;25(3):390-403.
5
Quality of life in cirrhosis is related to potentially treatable factors.肝硬化患者的生活质量与潜在可治疗因素有关。
Eur J Gastroenterol Hepatol. 2010 Feb;22(2):221-7. doi: 10.1097/MEG.0b013e3283319975.
6
Validation and Performance of Chronic Liver Disease Questionnaire (CLDQ-RO) in the Romanian Population.
J Gastrointestin Liver Dis. 2021 Jun 18;30(2):240-246. doi: 10.15403/jgld-3405.
7
Convergent validation of EQ-5D-5L in patients with Parkinson's disease.帕金森病患者中EQ-5D-5L的收敛效度验证。
J Neurol Sci. 2015 Nov 15;358(1-2):53-7. doi: 10.1016/j.jns.2015.08.010. Epub 2015 Aug 7.
8
Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30.应该使用哪种问卷来测量急性白血病患者的生活质量效用?对EQ-5D-5L以及源自欧洲癌症研究与治疗组织核心生活质量问卷(EORTC QLQ-C30)的基于偏好的问卷的有效性和可解释性的评估。
Value Health. 2016 Sep-Oct;19(6):834-843. doi: 10.1016/j.jval.2016.05.008. Epub 2016 Aug 26.
9
Health-Related Quality of Life: A Rapid Predictor of Hospitalization in Patients With Cirrhosis.健康相关生活质量:肝硬化患者住院的快速预测指标。
Am J Gastroenterol. 2020 Apr;115(4):575-583. doi: 10.14309/ajg.0000000000000545.
10
Validation of the Edmonton Symptom Assessment System: Ascites Modification.埃德蒙顿症状评估系统的验证:腹水改良版。
J Pain Symptom Manage. 2018 Jun;55(6):1557-1563. doi: 10.1016/j.jpainsymman.2018.03.016. Epub 2018 Mar 23.

引用本文的文献

1
Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-Series.经皮隧道式腹膜透析管治疗肝硬化难治性腹水:一项随机病例系列研究。
Medicina (Kaunas). 2020 Oct 27;56(11):565. doi: 10.3390/medicina56110565.
2
A survey of practice in management of malignancy-related ascites in Japan.日本恶性肿瘤相关性腹水管理实践调查。
PLoS One. 2019 Aug 9;14(8):e0220869. doi: 10.1371/journal.pone.0220869. eCollection 2019.

本文引用的文献

1
Review article: maximising quality of life while aspiring for quantity of life in end-stage liver disease.综述文章:在终末期肝病患者追求生存时长的同时最大化生活质量
Aliment Pharmacol Ther. 2017 Jul;46(1):16-25. doi: 10.1111/apt.14078. Epub 2017 May 2.
2
Malnutrition negatively impacts the quality of life of patients with cirrhosis: An observational study.营养不良对肝硬化患者的生活质量产生负面影响:一项观察性研究。
World J Hepatol. 2017 Feb 18;9(5):263-269. doi: 10.4254/wjh.v9.i5.263.
3
Glucose fluctuations reduce quality of sleep and of life in patients with liver cirrhosis.
血糖波动会降低肝硬化患者的睡眠质量和生活质量。
Hepatol Int. 2017 Jan;11(1):125-131. doi: 10.1007/s12072-016-9762-1. Epub 2016 Sep 13.
4
The societal burden of chronic liver diseases: results from the COME study.慢性肝病的社会负担:COME研究结果
BMJ Open Gastroenterol. 2015 Mar 30;2(1):e000025. doi: 10.1136/bmjgast-2014-000025. eCollection 2015.
5
Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial.一项随机试验中营养疗法对肝硬化合并轻微肝性脑病患者的疗效
Clin Gastroenterol Hepatol. 2016 Mar;14(3):454-460.e3; quiz e33. doi: 10.1016/j.cgh.2015.09.028. Epub 2015 Oct 8.
6
Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.低钠血症的纠正可改善肝硬化患者的认知、生活质量和脑水肿。
J Hepatol. 2015 Jan;62(1):75-82. doi: 10.1016/j.jhep.2014.07.033. Epub 2014 Aug 8.
7
Predictors of health-related quality of life in outpatients with cirrhosis: results from a prospective cohort.
Hepat Res Treat. 2013;2013:479639. doi: 10.1155/2013/479639. Epub 2013 Dec 22.
8
Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema.与肝硬化腹水患者生活质量相关的因素:血清钠浓度和腿部水肿的相关性。
J Hepatol. 2012 Dec;57(6):1199-206. doi: 10.1016/j.jhep.2012.07.020. Epub 2012 Jul 20.
9
The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers.肝硬化和肝性脑病给患者和照护者带来的多维负担。
Am J Gastroenterol. 2011 Sep;106(9):1646-53. doi: 10.1038/ajg.2011.157. Epub 2011 May 10.
10
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).新的 EQ-5D 五维版本(EQ-5D-5L)的制定和初步测试。
Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.